Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | CuttingEdgeInfo Reports | Reinventing Pharmaceutical Sales Forces (PH127)

Reinventing Pharmaceutical Sales Forces (PH127)

Rework your sales practices to reach and influence targets

The "more is better" methodology of selling is dead. The Wall Street Journal now predicts that the number of pharmaceutical sales reps in the US will drop to 70,000 by the year 2015. This is a tremendous change from the boom of the 1990s and early 2000s, when the total number of reps exceeded 100,000.

While some companies began adapting a few years ago, other companies now find themselves well behind. For those companies stuck in the past, reducing sales force mirroring, creating more personal relationships with targets, and uncovering new ways to reach physicians are the orders of the day. The companies that will excel will be those that innovate now and find new avenues for connecting with targets and that develop relationships where doctors actually call on reps for information.

Cutting Edge Information's Reinventing Pharmaceutical Sales Forces analyzes the current state of the pharmaceutical sales arena and reveals how innovative leaders are winning in a time when most companies find themselves in trouble.

The report makes its case with metrics and methodologies for preparing pharma sales forces to compete now and into the future. The report covers three main areas:

* Incorporating eDetailing and Closed Loop Marketing - Examines some of the newest ways sales forces are reaching physicians and meeting targets' specific needs.

* New Age Field Force Tactics - Studies the "new look" field force, which values one-on-one relationships between doctor and rep, fewer reps per district manager, a more technologically equipped team and increased rep accountability.

* Structures, Budgets and Sales Staff Compensation - Analyzes the sales force investment levels and resource allocations of today. The chapter also reveals compensation levels of newly hired, average and high-performing reps, district managers and regional managers.

Companies Included in the Report

* Abbott Laboratories

* Amgen

* Amylin

* Astellas

* Auriga Labs

* Axcan Pharma

* Barr

* Bayer Healthcare

* Baxter

* Boehringer-Ingelheim

* Bristol-Myers Squibb

* Centocor-Ortho Biotech

* Cubist

* GlaxoSmithKline

* Johnson & Johnson

* MedImmune

* Merck

* Novartis

* Novo Nordisk

* Ortho-McNeil

* Pfizer

* Purdue Pharma

* Quinnova Pharmaceuticals

* Schering-Plough

* Solvay Pharmaceuticals

* Somaxon Pharmaceuticals

* Sucampo Pharmaceutical

* Teva

* Wyeth

* ... plus more

Published 2009

141 Pages

500+ Metrics

90+ Charts and Diagrams

Table of Contents
Price: $7,695.00 / €5,096.40

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions